| A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength EE Hassan, JM Gallo Pharmaceutical research 7, 491-495, 1990 | 525 | 1990 |
| Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole EE Hassan, RC Parish, JM Gallo Pharmaceutical research 9, 390-397, 1992 | 257 | 1992 |
| New strategies to deliver anticancer drugs to brain tumors V Laquintana, A Trapani, N Denora, F Wang, JM Gallo, G Trapani Expert opinion on drug delivery 6 (10), 1017-1032, 2009 | 243 | 2009 |
| Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2), a beta integrin antagonist, in patients with solid tumours ME Cianfrocca, KA Kimmel, J Gallo, T Cardoso, MM Brown, G Hudes, ... British journal of cancer 94 (11), 1621-1626, 2006 | 203 | 2006 |
| Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. PJ O'Dwyer, TC Hamilton, FP LaCreta, JM Gallo, D Kilpatrick, T Halbherr, ... Journal of clinical oncology 14 (1), 249-256, 1996 | 201 | 1996 |
| A new model for prediction of drug distribution in tumor and normal tissues: pharmacokinetics of temozolomide in glioma patients L Rosso, CS Brock, JM Gallo, A Saleem, PM Price, FE Turkheimer, ... Cancer research 69 (1), 120-127, 2009 | 189 | 2009 |
| Merging systems biology with pharmacodynamics R Iyengar, S Zhao, SW Chung, DE Mager, JM Gallo Science translational medicine 4 (126), 126ps7-126ps7, 2012 | 168 | 2012 |
| Distribution of small magnetic particles in brain tumor-bearing rats SK Pulfer, SL Ciccotto, JM Gallo Journal of neuro-oncology 41, 99-105, 1999 | 164 | 1999 |
| Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide Q Zhou, P Guo, JM Gallo Clinical Cancer Research 14 (5), 1540-1549, 2008 | 163 | 2008 |
| Pharmacodynamic-mediated reduction of temozolomide tumor concentrations by the angiogenesis inhibitor TNP-470 J Ma, S Pulfer, S Li, J Chu, K Reed, JM Gallo Cancer research 61 (14), 5491-5498, 2001 | 157 | 2001 |
| The effect of P-glycoprotein on paclitaxel brain and brain tumor distribution in mice JM Gallo, S Li, P Guo, K Reed, J Ma Cancer research 63 (16), 5114-5117, 2003 | 152 | 2003 |
| Analysis of albumin microsphere preparation JM Gallo, CT Hung, DG Perrier International journal of pharmaceutics 22 (1), 63-74, 1984 | 139 | 1984 |
| Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat JM Gallo, PK Gupta, CT Hung, DG Perrier Journal of pharmaceutical sciences 78 (3), 190-194, 1989 | 132 | 1989 |
| Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models AK Tiwari, K Sodani, C Dai, AH Abuznait, S Singh, ZJ Xiao, A Patel, ... Cancer letters 328 (2), 307-317, 2013 | 126 | 2013 |
| Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies GR Hudes, CE Szarka, A Adams, S Ranganathan, RA McCauley, ... Clinical cancer research 6 (8), 3071-3080, 2000 | 125 | 2000 |
| Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2', 3'-dideoxyuridine and 3'-azido-3'-deoxythymidine CK Chu, VS Bhadti, KJ Doshi, JT Etse, JM Gallo, FD Boudinot, ... Journal of medicinal chemistry 33 (8), 2188-2192, 1990 | 118 | 1990 |
| Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model Q Zhou, JM Gallo Neuro-oncology 11 (3), 301-310, 2009 | 113 | 2009 |
| Multidrug resistance protein 4 protects bone marrow, thymus, spleen, and intestine from nucleotide analogue–induced damage MG Belinsky, P Guo, K Lee, F Zhou, E Kotova, A Grinberg, H Westphal, ... Cancer research 67 (1), 262-268, 2007 | 112 | 2007 |
| Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice GD Kruh, MG Belinsky, JM Gallo, K Lee Cancer and Metastasis Reviews 26, 5-14, 2007 | 111 | 2007 |
| Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz. PJ O'Dwyer, CE Szarka, KS Yao, TC Halbherr, GR Pfeiffer, F Green, ... The Journal of clinical investigation 98 (5), 1210-1217, 1996 | 109 | 1996 |
